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Abstract
Hemangioma is the most common benign liver tumor and
the second most common liver tumor after metastases.
Large hemangiomas are often heterogeneous. When they
exceed 4 cm in diameter, they are termed giant
hemangiomas. These giant hemangiomas often present
heterogeneous patterns. These heterogeneous appearances
are shown because of intratumoral changes due to several
degenerative phenomena. PET/CT is reported to be useful
for the differentiation of benign from malignant liver
lesions. We report the case of a large hepatic hemangioma
characterized by high FDG uptake.
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Case
These findings suggested for a giant hemangioma, the most
common benign liver tumor [1] (Figure 1). Large hemangiomas
often present heterogeneous patterns and these heterogeneous
appearances are shown because of intratumoral changes such as
hemorrhage, thrombosis, extensive hyalinization, necrosis and
fibrosis [2]. PET/CT is reported to be useful for the
differentiation of benign from malignant liver lesions [3]. PET/CT
scan demonstrated high FDG uptake compared to normal liver
parenchyma. The lesion was also analyzed semi quantitatively
using the SUV (Standardized uptake value) and L/B (Lesion to
liver background) ratio. The maximum SUV for the lesion was 5.3
and L/B ratio was 2.3. This PET/CT scan was compared with
previous PET/CT examination that showed high FDG uptake of
the lesion as compared to the normal liver parenchyma. It is well
known that benign liver lesions do not accumulate FDG more
than normal liver background [4], considering a cut-off level to
differentiate benign from malignant liver masses as 2 for the L/B
ratio and 3.5 for the SUV of the lesion.
Figure 1: A 50 year-old woman underwent 18F-FDG Whole
Body FDG-PET scan for lung cancer follow-up. [A]
Unenhanced CT scan transaxial slice showed a
hypoattenuating and heterogeneous lesion of 8 cm in
diameter. [B] Located on the second segment of the left lobe
of the liver. After intravenous administration of contrast
material, arterial-phase CT showed early, peripheral, globular
enhancement of the lesion. [C] Venous-phase CT showed
centripetal enhancement [D] Delayed-phase CT scan showed
isoattenuating areas with no complete filling of the lesion.
The lesion in our study showed typical hemangioma contrast
enhancing during CT scan, like hepatic epithelioid
hemangioendothelioma, a rare tumor of vascular origin [5,6].
Giant hemangioma which high SUV and high L/B ratio showed
difficulties to differentiate it from other malignant lesions. FDG
uptake can be explained by various hypotheses. Giant
hemangioma can degenerate into a malignant tumor, the
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angiosarcoma. To our knowledge in the literature there is only
one report of malignant transformation of hepatic hemangioma
[7]. Another report described an angiosarcoma surrounding a
cavernous hemangioma raising the hypothesis of malignant
transformation of a hemangioma [8]. However the lesion of our
case did not show changes in dimensions over time. One other
hypothesis is that hemangiomas can have inflammatory
features. This inflammatory process can explain glucose
consumption thus high FDG uptake. The last hypothesis is
connected with tissue metabolism. Benign tumors show normal
to decreased metabolism. But these benign lesions can have
hypermetabolic patterns showing increased FDG uptake.
Hypervascularization and slowed down “wash-out” can lead to
glucose accumulation. Necrotic areas within the lesion better
support the last hypothesis.
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